LMO2 as a Biomarker for Hypersensitivity to Genotoxic Therapy.

Scuoppo, Claudio; Zha, Shan

Scuoppo, Claudio; Zha, Shan.

Afiliação

Scuoppo C; Institute for Cancer Genetics, Vagelos College for Physicians and Surgeons, Columbia University, New York, NY 10032, USA; Department of Pathology and Cell Biology, Vagelos College for Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Zha S; Institute for Cancer Genetics, Vagelos College for Physicians and Surgeons, Columbia University, New York, NY 10032, USA; Department of Pediatrics, Vagelos College for Physicians and Surgeons, Columbia University, New York, NY 10032, USA; Department of Pathology and Cell Biology, Vagelos College for Physicians and Surgeons, Columbia University, New York, NY 10032, USA; Department of Immunology and Microbiology, Vagelos College for Physicians and Surgeons, Columbia University, New York, NY 10032,

Cancer Cell ; 36(3): 211-212, 2019 09 16.

Article em En | MEDLINE | ID: mdl-31526755

Assuntos

Proteínas com Domínio LIM; Inibidores de Poli(ADP-Ribose) Polimerases; Proteínas Adaptadoras de Transdução de Sinal; Dano ao DNA; Proteínas Proto-Oncogênicas/genética; Mutações Sintéticas Letais

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas com Domínio LIM / Inibidores de Poli(ADP-Ribose) Polimerases Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google